Synergistic inhibition by β2-agonists and corticosteroids on tumor necrosis factor-α-induced interleukin-8 release from cultured human airway smooth-muscle cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 23, Issue 1, 2000, Pages 79-85

  Pang, Linhua ^a   Knox, Alan J ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033899452     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.23.1.3985     Document Type: Article

References (38)

1. 1. Barnes, P. J. 1992. New aspects of asthma. J. Intern. Med. 231:453-461.
2. 2. Barnes, P. J. 1995. Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332:868-875.
3. 3. Vathenen, A. S., A. J. Knox, B. G. Higgins, J. R. Britton, and A. E. Tattersfield. 1988. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1:554-558.
4. 4. Cockroft, D. W., C. P. McParland, S. A. Britto, V. A. Swystun, and B. C. Rutherford. 1993. Regular inhaled Salbutamol and airways responsiveness to allergen. Lancet 342:833-837.
5. 5. Greening, A. P., P. W. Ind, M. Northfield, and G. Shaw. 1994. Added salmeterol versus higher dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344:219-224.
6. 6. Woolcock, A., B. Lundback, N. Ringdal, and L. A. Jacques. 1996. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am. J. Respir. Crit. Care Med. 153:1481-1488.
7. 7. Pauwels, R. A., C. G. Lofdahl, D. S. Postma, A. E. Tattersfield, P. M. O'Byrne, P. J. Barnes, and A. Ullman. 1997. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 337:1405-1411.
8. 8. Wilding, P. M., J. T. Clark, S. Coon, S. Lewis, L. Rushton, J. Bennett, J. Obourne, S. Cooper, and A. Tattersfield. 1997. Effect of long term treatment with salmeterol on asthma control: a double blind, randomised cross-over study. Br. Med. J. 314:1441-1446.
9. 9. Djukanovic, R., W. R. Roche, J. W. Wilson, C. R. W. Beasley, O. P. Twentyman, P. H. Howarth, and S. T. Holgate. 1990. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142:434-457.
10. 10. Fahy, J. V., K. W. Kim, J. Liu, and H. Boushey. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbations. J. Allergy Clin. Immunol. 95:843-852.
11. 11. Sur, S., T. B. Crotty, G. M. Kephart, B. A. Hyma, T. U. Colby, C. E. Reed, L. W. Hunt, and G. J. Gleich. 1993. Sudden onset fatal asthma: a distinct entity with few cosinophils and relatively more neutrophils in the airway submucosa. Am. Rev. Respir. Dis. 148:713-719.
12. 12. Turner, M. O., P. Husack, M. R. Sean, J. Dolovich, and F. E. Hargreave. 1995. Exacerbations of asthma without sputum eosinophilia. Thorax 50: 1057-1061.
13. 13. Wenzel, S. E., S. J. Szefter, D. Y. M. Leung, S. I. Sloan, M. D. Rex, and R. J. Martin. 1997. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose corticosteroids. Am. J. Respir. Crit. Care Med. 156:737-743.
14. 14. Gavreau, G. M., R. M. Watson, M. Jordana, D. Cockroft, and P. M. O'Byrne. 1995. The effect of regular inhaled salbutamol on allergen-induced airway responses and inflammatory cells in blood and induced sputum. Am. J. Respir. Crit. Care Med. 151:A39. (Abstr.)
15. 15. Anticevitch, S. Z., J. M. Hughes, J. L. Black, and C. L. Armour. 1996. Induction of hyper-responsiveness in human airway tissue by neutrophils, mechanism of action. Clin. Exp. Allergy 26:549-556.
16. 16. Shute, J. K., B. Vrugt, I. S. D. Lindley, S. T. Holgate, A. Bron, R. Aalbers, and R. Djukanovic. 1997. Free and complexed IL-8 in blood and bronchial mucosa in asthma. Am. J. Respir. Crit. Care Med. 155:1877-1883.
17. 17. Nocker, R. E., D. F. M. Schoonbrood, E. A. Vandegraaf, C. E. Hack, R. Lutter, H. M. Jansen, and T. A. Out. 1996. Interleukin-8 in airway inflammation in patients with asthma and COPD. Int. Arch. Allergy Immunol. 109:183-191.
18. 18. Chanez, P., I. Enander, I. Jones, P. Godard, and J. Bousquet. 1996. Interleukin-8 in bronchoalveolar lavage of asthmatic and chronic bronchitic patients. Int. Arch. Allergy Immunol. 111:83-88.
19. 19. Erger, R. A., and T. B. Casale. 1998. Interleukin-8 plays a significant role in IgE mediated lung inflammation. Eur. Respir. J. 11:299-305.
20. 20. Pang, L. H., E. Holland, and A. J. Knox. 1998. Bradykinin stimulates interleukin-8 production in cultured human airway smooth muscle cells: role of cyclooxygenase products. J. Immunol. 161:2509-2515.
21. 21. John, M., B. T. Au, P. J. Jose, S. Lim, P. J. Barnes, J. A. Mitchell, M. G. Belvisi, and K. F. Chung. 1998. Expression and release of interleukin-8 by HASM cells: inhibition by Th-2 cytokines and corticosteroids. Am. J. Respir. Cell Mol. Biol. 18:84-90.
22. 22. Johnson, S., and A. J. Knox. 1997. Synthetic functions of airway smooth muscle in asthma. Trends Pharmacol. Sci. 18:288-292.
23. 23. Spina, D., P. J. Rigby, J. W. Paterson, and R. G. Goldie. 1989. Autoradiographic localisation of beta adrenoceptors in asthmatic human lung. Am. Rev. Respir. Dis. 140:1410-1415.
24. 24. Broide, D. H., M. Lotz, A. Cuomo, D. A. Coburn, E. L. Federman, and S. I. Wasserman. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958-967.
25. 25. Thomas, P. S., D. H. Yates, and P. J. Barnes. 1995. Tumour necrosis factor α increases airway hyper-responsiveness and sputum neutrophilia in normal subjects. Am. J. Respir. Crit. Care Med. 152:76-80.
26. 26. Pang, L. H., and A. J. Knox. 1997. Effect of interleukin-1β, tumour necrosis factor-α and interferon-γ on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Br. J. Pharmacol. 121:579-587.
27. 2 release by bradykinin in human airway smooth muscle cells: involvement of cyclooxygenase-2 induction. Am. J. Physiol. 273 (Lung Cell. Mol. Physiol.):L1132-L1140.
28. 28. SPSS, Inc. 1996. SPSS Base for Windows User's Guide. SPSS, Inc., Chicago. 564.
29. 29. Kase, H., K. Iwahashi, S. Nakanishi, Y. Matsuda, K. Yamada, M. Takahashi, C. Murakata, A. Sato, and M. Kaneko. 1987. K-252 compounds, novel and potent inhibitors of protein kinase-C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142:436-440.
30. 30. Torphy, T. J., and B. J. Undem. 1991. Phosphodiesterase inhihitors: new opportunities for the treatment of asthma. Thorax 46:512-523.
31. 31. Linden, A. 1996. Increased interleukin-8 release by beta-adrenoceptor activation in human transformed bronchial epithelial cells. Br. J. Pharmacol. 119:402-406.
32. 2 stimulates IL-8 gene expression in human colonic epithelial cells by a post transcriptional mechanism. J. Immunol. 161:3746-3752.
33. 33. Pang, L. H., E. Holland, and A. J. Knox. 1998. Role of cyclooxygenase-2 induction in interleukin 1β induced attenuation of cultured human airway smooth muscle cell cyclic AMP generation in response to isoprenaline. Br. J. Pharmacol. 125:1320-1328.
34. 34. Bilski, A. J., S. E. Halliday, J. D. Fitzgerald, and J. L. Wade. 1983. The pharmacology of a beta-2 selective adrenoceptor antagonist ICI-118,551. J. Cardiovasc. Pharmacol. 5:430-437.
35. 35. Yasumoto, K., S. Okamoto, N. Mukaida, S. Murakami, M. Mai, and K. Matsushima. 1992. Tumour necrosis factor alpha and interferon gamma synergistically induce interleukin-8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB like binding sites of the interleukin-8 gene. J. Biol. Chem. 267:22506-22511.
36. 36. Brasier, A. R., M. Jamaladdin, A. Casola, W. Duan, Q. Shen, and R. P. Garofalo. 1998. A promoter recruitment mechanism for TNFα induced IL-8 transcription in type II pulmonary epithelial cells. J. Biol. Chem. 273:3551-3561.
37. 2 adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J. Biol. Chem. 274:1005-1010.
38. 38. Odera, S., M. Vestri, R. Testi, and G. A. Rossi. 1998. Salmeterol enhances the inhibiting activity of dexamethasone on allergen-induced blood mononuclear cell activation. Respiration 65:199-204.